{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:09:51Z","timestamp":1777511391205,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10753-021-01565-1","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T06:06:49Z","timestamp":1633586809000},"page":"544-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Performance of High Mobility Protein Group 1 and Interleukin-6 as Predictors of Outcomes Resulting from Variceal Bleeding in Patients with Advanced Chronic Liver Disease"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3844-6716","authenticated-orcid":false,"given":"Camilla","family":"dos Santos Pinheiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9lio Geraldo","family":"de Oliveira Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Ribeiro Lima Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludmila Resende","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique Carvalho","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto Gardone","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Ant\u00f4nio Castro","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saulo Fernandes","family":"Saturnino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanuza Chagas","family":"do Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus Vinicius Melo","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Garcia","family":"Vilela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"issue":"6","key":"1565_CR1","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1053\/j.gastro.2008.03.007","volume":"134","author":"AJ Sanyal","year":"2008","unstructured":"Sanyal, A.J., J. Bosch, A. Blei, and V. Arroyo. 2008. Portal hypertension and its complications. Gastroenterology 134 (6): 1715\u20131728.","journal-title":"Gastroenterology"},{"issue":"3","key":"1565_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis, R., and B.V. Faculty. 2015. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. Journal of Hepatology 63 (3): 743\u2013752.","journal-title":"Journal of Hepatology"},{"key":"1565_CR3","first-page":"1","volume":"19","author":"JS Bajaj","year":"2011","unstructured":"Bajaj, J.S. 2011. Sanyal AJ. Treatment of active variceal hemorrhage. 19: 1\u201316.","journal-title":"Treatment of active variceal hemorrhage."},{"key":"1565_CR4","unstructured":"M\u00e3o de Ferro S.,  M.S. Salazar,  M. Mariana,  F. Ramalho, and H.C. Pinto.\u00a02011. Intestinal permeability in patients with liver cirrhosis: correlation with endotoxemia and circulating levels of TNF\u03b1, IL-1 and IL-6. Portuguese Journal of Gastroenterology\u00a018: 66\u201372."},{"key":"1565_CR5","first-page":"146","volume":"18","author":"A Santos","year":"2011","unstructured":"Santos, A. 2011. Intestinal permeability in patients with liver cirrhosis: Some facts, many doubts. Portuguese Journal of Gastroenterology. 18: 146\u2013147.","journal-title":"Portuguese Journal of Gastroenterology."},{"issue":"6","key":"1565_CR6","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","volume":"61","author":"A Albillos","year":"2014","unstructured":"Albillos, A., M. Lario, and M. \u00c1lvarez-Mon. 2014. Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance. Journal of Hepatology 61 (6): 1385\u20131396.","journal-title":"Journal of Hepatology"},{"issue":"1","key":"1565_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","volume":"60","author":"R Wiest","year":"2014","unstructured":"Wiest, R., M. Lawson, and M. Geuking. 2014. Pathological bacterial translocation in liver cirrhosis. Journal of Hepatology 60 (1): 197\u2013209.","journal-title":"Journal of Hepatology"},{"issue":"5","key":"1565_CR8","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1021\/acsnano.0c02633","volume":"14","author":"J Zhang","year":"2020","unstructured":"Zhang, J., H. Shen, J. Xu, L. Liu, J. Tan, M. Li, et al. 2020. Liver-targeted siRNA lipid nanoparticles treat hepatic cirrhosis by dual antifibrotic and anti-inflammatory activities. ACS Nano 14 (5): 6305\u20136322.","journal-title":"ACS Nano"},{"issue":"1","key":"1565_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41423-020-00580-w","volume":"18","author":"Y He","year":"2021","unstructured":"He, Y., S. Hwang, Y.A. Ahmed, D. Feng, N. Li, M. Ribeiro, et al. 2021. Immunopathobiology and therapeutic targets related to cytokines in liver diseases. Cellular & Molecular Immunology 18 (1): 18\u201337.","journal-title":"Cellular & Molecular Immunology"},{"issue":"4","key":"1565_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1590\/s0004-2803.201800000-75","volume":"55","author":"EG Vilela","year":"2018","unstructured":"Vilela, E.G., C.D.S. Pinheiro, S.F. Saturnino, C.G.O. Gomes, V.C.D. Nascimento, and M.V.M. Andrade. 2018. Evaluation of the behavior of levels of HMGB1 and IL-6 as predictors of infection, acute kidney injury and mortality in cirrhotic patients with variceal bleeding. Arquivos de Gastroenterologia 55 (4): 338\u2013342.","journal-title":"Arquivos de Gastroenterologia"},{"key":"1565_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","volume":"12","author":"AA Mokdad","year":"2014","unstructured":"Mokdad, A.A., A.D. Lopez, S. Shahraz, R. Lozano, A.H. Mokdad, J. Stanaway, et al. 2014. Liver cirrhosis mortality in 187 countries between 1980 and 2010: A systematic analysis. BMC Medicine 12: 145.","journal-title":"BMC Medicine"},{"issue":"2","key":"1565_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jhep.2013.10.004","volume":"60","author":"J Cordoba","year":"2014","unstructured":"Cordoba, J., M. Ventura-Cots, M. Sim\u00f3n-Talero, \u00c0. Amor\u00f3s, M. Pavesi, H. Vilstrup, et al. 2014. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). Journal of Hepatology 60 (2): 275\u2013281.","journal-title":"Journal of Hepatology"},{"issue":"5","key":"1565_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1053\/j.gastro.2015.03.023","volume":"148","author":"F Kanwal","year":"2015","unstructured":"Kanwal, F. 2015. Decreasing mortality in patients hospitalized with cirrhosis. Gastroenterology 148 (5): 897\u2013900.","journal-title":"Gastroenterology"},{"issue":"4","key":"1565_CR14","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.mayocp.2018.12.020","volume":"94","author":"DA Simonetto","year":"2019","unstructured":"Simonetto, D.A., M. Liu, and P.S. Kamath. 2019. Portal hypertension and related complications: Diagnosis and management. Mayo Clinic Proceedings 94 (4): 714\u2013726.","journal-title":"Mayo Clinic Proceedings"},{"issue":"17","key":"1565_CR15","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1056\/NEJMra1600561","volume":"375","author":"EF Wijdicks","year":"2016","unstructured":"Wijdicks, E.F. 2016. Hepatic encephalopathy. New England Journal of Medicine 375 (17): 1660\u20131670.","journal-title":"New England Journal of Medicine"},{"key":"1565_CR16","doi-asserted-by":"crossref","unstructured":"Arroyo V.,  R. Moreau,  R. Jalan, and P. Gin\u00e8s\u00a02015. Study E-CCC. Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis. Journal of Hepatology 62(1 Suppl): S131\u201343.","DOI":"10.1016\/j.jhep.2014.11.045"},{"issue":"5","key":"1565_CR17","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.jhep.2012.12.025","volume":"58","author":"S Gandoura","year":"2013","unstructured":"Gandoura, S., E. Weiss, P.E. Rautou, M. Fasseu, T. Gustot, F. Lemoine, et al. 2013. Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis. Journal of Hepatology 58 (5): 936\u2013948.","journal-title":"Journal of Hepatology"},{"key":"1565_CR18","doi-asserted-by":"crossref","unstructured":"Doi, K., and H. Rabb. 2016. Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic targets. Kidney International 89 (3): 555\u201364.","DOI":"10.1016\/j.kint.2015.11.019"},{"issue":"4","key":"1565_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nri1594","volume":"5","author":"MT Lotze","year":"2005","unstructured":"Lotze, M.T., and K.J. Tracey. 2005. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nature Reviews Immunology 5 (4): 331\u2013342.","journal-title":"Nature Reviews Immunology"},{"key":"1565_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2119\/molmed.2013.00099","volume":"19","author":"R Chen","year":"2013","unstructured":"Chen, R., W. Hou, Q. Zhang, R. Kang, X.G. Fan, and D. Tang. 2013. Emerging role of high-mobility group box 1 (HMGB1) in liver diseases. Molecular Medicine 19: 357\u2013366.","journal-title":"Molecular Medicine"},{"issue":"2","key":"1565_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/hep.20766","volume":"42","author":"L Ruiz-del-Arbol","year":"2005","unstructured":"Ruiz-del-Arbol, L., A. Monescillo, C. Arocena, P. Valer, P. Gin\u00e8s, V. Moreira, et al. 2005. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 42 (2): 439\u2013447.","journal-title":"Hepatology"},{"issue":"3","key":"1565_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ki.2014.338","volume":"87","author":"D Adebayo","year":"2015","unstructured":"Adebayo, D., V. Morabito, A. Davenport, and R. Jalan. 2015. Renal dysfunction in cirrhosis is not just a vasomotor nephropathy. Kidney International 87 (3): 509\u2013515.","journal-title":"Kidney International"},{"issue":"3","key":"1565_CR23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/liv.12047","volume":"33","author":"N Shah","year":"2013","unstructured":"Shah, N., F.E. Mohamed, M. Jover-Cobos, J. Macnaughtan, N. Davies, R. Moreau, et al. 2013. Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis. Liver International 33 (3): 398\u2013409.","journal-title":"Liver International"},{"issue":"5","key":"1565_CR24","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jhep.2011.11.024","volume":"56","author":"N Shah","year":"2012","unstructured":"Shah, N., D. Dhar, Mohammed F. El Zahraa, A. Habtesion, N.A. Davies, M. Jover-Cobos, et al. 2012. Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. Journal of Hepatology 56 (5): 1047\u20131053.","journal-title":"Journal of Hepatology"},{"issue":"7","key":"1565_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00011-013-0624-1","volume":"62","author":"X Li","year":"2013","unstructured":"Li, X., L.K. Wang, L.W. Wang, X.Q. Han, F. Yang, and Z.J. Gong. 2013. Blockade of high-mobility group box-1 ameliorates acute on chronic liver failure in rats. Inflammation Research 62 (7): 703\u2013709.","journal-title":"Inflammation Research"},{"issue":"11","key":"1565_CR26","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1681\/ASN.2009101048","volume":"21","author":"H Wu","year":"2010","unstructured":"Wu, H., J. Ma, P. Wang, T.M. Corpuz, U. Panchapakesan, K.R. Wyburn, et al. 2010. HMGB1 contributes to kidney ischemia reperfusion injury. Journal of the American Society of Nephrology 21 (11): 1878\u20131890.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"1565_CR27","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/hep.26980","volume":"60","author":"JM Belcher","year":"2014","unstructured":"Belcher, J.M., A.J. Sanyal, A.J. Peixoto, M.A. Perazella, J. Lim, H. Thiessen-Philbrook, et al. 2014. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology 60 (2): 622\u2013632.","journal-title":"Hepatology"},{"key":"1565_CR28","doi-asserted-by":"publisher","first-page":"2867241","DOI":"10.1155\/2020\/2867241","volume":"2020","author":"CG de Oliveira Gomes","year":"2020","unstructured":"de Oliveira Gomes, C.G., M.V.M. de Andrade, L.R. Guedes, H.C. Rocha, R.G. Guimar\u00e3es, F.A.C. Carvalho, et al. 2020. Evaluation of the biomarkers HMGB1 and IL-6 as predictors of mortality in cirrhotic patients with acute kidney injury. Mediators of Inflammation 2020: 2867241.","journal-title":"Mediators of Inflammation"},{"issue":"2","key":"1565_CR29","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","volume":"33","author":"PS Kamath","year":"2001","unstructured":"Kamath, P.S., R.H. Wiesner, M. Malinchoc, W. Kremers, T.M. Therneau, C.L. Kosberg, et al. 2001. A model to predict survival in patients with end-stage liver disease. Hepatology 33 (2): 464\u2013470.","journal-title":"Hepatology"},{"issue":"3","key":"1565_CR30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/lt.20329","volume":"11","author":"AE Ruf","year":"2005","unstructured":"Ruf, A.E., W.K. Kremers, L.L. Chavez, V.I. Descalzi, L.G. Podesta, and F.G. Villamil. 2005. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transplantation 11 (3): 336\u2013343.","journal-title":"Liver Transplantation"},{"key":"1565_CR31","unstructured":"Fischer J. 2016. Circulating interleukin levels 6, 10 and 17 as prognostic markers in liver cirrhosis. Dissertation - Federal University of Santa Catarina, Health Sciences Center. Graduate Program in Medical Sciences\u00a01\u2013139."},{"key":"1565_CR32","doi-asserted-by":"crossref","unstructured":"Liboredo, J.C., E.G. Vilela, Ferrari MeL,  A.S. Lima, and M.I. Correia. 2015. Nutrition status and intestinal permeability in patients eligible for liver transplantation. JPEN Journal of Parenteral Enteralal Nutrition 39 (2): 163\u2013170.","DOI":"10.1177\/0148607113513465"},{"issue":"2","key":"1565_CR33","first-page":"91","volume":"25","author":"T Ascione","year":"2017","unstructured":"Ascione, T., G. Di Flumeri, G. Boccia, and F. De Caro. 2017. Infections in patients affected by liver cirrhosis: An update. Le Infezioni in Medicina 25 (2): 91\u201397.","journal-title":"Le Infezioni in Medicina"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-021-01565-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-021-01565-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-021-01565-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T06:15:30Z","timestamp":1648188930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-021-01565-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1565"],"URL":"https:\/\/doi.org\/10.1007\/s10753-021-01565-1","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]},"assertion":[{"value":"14 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Research Ethics Committee of the Universidade Federal de Minas Gerais, CAAE 52609516.9.000.5149.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The patients who agreed to participate or their legal representatives signed the Free and Informed Consent Form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}